ACP
Acuta Capital Partners’s Trevi Therapeutics TRVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7M | Sell |
493,735
-292,226
| -37% | -$1.6M | 3.77% | 11 |
|
|
2025
Q1 | $4.94M | Buy |
785,961
+14,003
| +2% | +$88.1K | 5.73% | 6 |
|
|
2024
Q4 | $3.18M | Buy |
771,958
+481,458
| +166% | +$1.98M | 3.2% | 11 |
|
|
2024
Q3 | $970K | Buy |
290,500
+30,500
| +12% | +$102K | 0.79% | 26 |
|
|
2024
Q2 | $775K | Buy |
+260,000
| New | +$775K | 0.65% | 24 |
|
|
2022
Q4 | – | Sell |
-36,302
| Closed | -$56K | – | 46 |
|
|
2022
Q3 | $56K | Buy |
36,302
+1,302
| +4% | +$2.01K | 0.02% | 44 |
|
|
2022
Q2 | $98K | Buy |
+35,000
| New | +$98K | 0.05% | 39 |
|